Alpha Signal Monitor - Daily Market Briefing | November 28, 2025
Daily Market Research Report
November 28, 2025
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Street outlook check: GLD / IAU / BAR (as of Nov 28, 2025)
Trading Idea: Buy Rationale (TL;DR): Consensus from major houses skews bullish into 2026 on continued central-bank accumulation, resumed ETF inflows and an easing-rate backdrop; most banks lifted 2026 gold targets to ~$4,450–$5,000/oz, supporting long exposure via GLD/IAU/BAR despite near‑term volatility.
2025’s record run in gold has been fueled by policy and geopolitical uncertainty, with banks highlighting strong official-sector buying (~700–1,000t quarterly/annually), a turn toward Fed easing supporting ETF demand, and deficits/currency-debasement narratives; several desks expect these supports to persist into 2026.
Key Drivers - Central‑bank demand staying elevated into 2025–26, with UBS/J.P. Morgan citing ~900–1,000t annual purchases. - Re‑acceleration of ETF inflows after multi‑year outflows, enhancing price elasticity on dips. - Fed easing cycle and lower real yields improving non‑yielding bullion’s relative appeal. - Persistent policy/geopolitical risk and fiscal deficits sustaining private investment demand.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | $4,900/oz by Dec‑2026 (media citing GS); $4,000 by mid‑2026 per GS Research. | GS attributes upside to structural central‑bank demand and an easing cycle that should revive ETF inflows; house materials point to $4,000 by mid‑2026, while press coverage cites a later $4,900 target for end‑2026. | 2025-10-07 | https://www.goldmansachs.com/insights/articles/gold-forecast-to-rise-by-the-middle-of-2026 |
| Morgan Stanley | - | - | MS Wealth Management notes precious metals have “decent upside potential,” with gold potentially part of a secular collateral story; they emphasize real assets’ diversification role rather than explicit price targets. | 2025-11-06 | https://www.morganstanley.com/campaigns/wealth-management/move-report/move-report2025nov6 |
| JP Morgan | - | $5,055/oz by Q4‑2026; ~$3,675/oz by Q4‑2025; ~$4,000 by mid‑2026. | JPM calls gold a highest‑conviction long into the Fed cutting cycle; base case lifts 2026 average toward $5,055 on combined central‑bank/investor demand, with 2025 Q4 at ~$3,675 and ~$4,000 by mid‑2026. | 2025-10-24 | https://www.mining.com/gold-price-could-reach-5055-by-q4-2026-says-jpmorgan/ |
| Bank of America | - | $5,000/oz (2026), ~${4,400}/oz average in 2026. | BofA Global Research raised its 2026 target to $5,000 with an average near $4,400, citing rate‑cut tailwinds, persistent macro uncertainty and improving ETF demand. | 2025-10-13 | https://www.investing.com/news/economy-news/factboxbofa-hikes-gold-price-forecast-to-5000oz-for-2026-4283688 |
| Citigroup | - | Near‑term (0–3m) $3,800 (cut from $4,000 on Oct 28); 6–12m ~$3,000; base case sees sub‑$3,000 by late‑2025/early‑2026 with potential $2,500–$2,700 by H2‑2026. | Citi turned more cautious, trimming short‑term targets and flagging scope for a retracement below $3,000 as investment demand fades with firmer growth; earlier in 2025 they briefly raised the 3‑month target to $3,500 on China/ETF flows. | 2025-10-28 | https://www.investing.com/news/economy-news/factboxciti-downgrades-shortterm-gold-silver-price-forecasts-4312324 |
| UBS | Most Preferred | Base case $3,500/oz across forecast tenors (with $3,800 upside / $3,200 downside). | UBS CIO remains Most Preferred on gold, lifting the base‑case target to $3,500 with an upside/downside range of $3,800/$3,200 and highlighting 2025 official‑sector buying around 1,000t and revived ETF demand. | 2025-04-11 | https://www.ubs.com/global/en/wealthmanagement/insights/marketnews/article.2089596.html |
| HSBC | Tactical Overweight | Peak around ~$4,400 in 1H‑2026; 2026 average ~ $4,600/oz (various notes/media summaries). | HSBC Private Bank kept a tactical overweight on gold; house commentary says the rally could extend into 2026 but fade later as real rates re‑assert, while press roundups cite a ~$4,400 peak and ~$4,600 2026 average. | 2025-10-13 | https://www.expat.hsbc.com/wealth/insights/fx-insights/fx-viewpoint/gold-smashed-through-usd4000-oz/ |
| Deutsche Bank | - | 2026 average $4,450/oz (range ~$3,950–$4,950); 2027 $5,150/oz. | DB raised its 2026 average to $4,450 (kept 2027 at $5,150) on tight physical markets, strong CB demand and returning ETF inflows, while noting risks if policy easing is limited or reserve purchases slow. | 2025-11-26 | https://www.reuters.com/business/deutsche-bank-raises-2026-gold-price-forecast-4450oz-2025-11-26/ |
Risk Considerations - Upside surprise in real yields/US dollar that crimps ETF/OTC investment demand. - Central‑bank buying slows from recent highs, or China retail/jewelry demand weakens at elevated prices. - Fewer/later Fed cuts than expected; easing of trade/geopolitical tensions removes safe‑haven bid. - Volatility from sharp positioning swings after a parabolic 2025 rally.
Position long bias in GLD/IAU/BAR with expectation of continued strength into 2026 but allow for 10–15% drawdowns; scale entries on dips and monitor ETF flow trends, USD/real‑rate path and official‑sector purchases. For asset‑allocation context, UBS continues to advocate ~5% strategic gold exposure as a portfolio hedge.
Stock Ratings — Street Targets & Ratings — Big Tech coverage from GS/MS/JPM/BofA/Citi/Wells (as of Nov 28, 2025)
Below is a structured consolidation of the latest publicly-reported 12‑month target prices and ratings from the requested six institutions for each stock. Dates are the most recent noted update we could locate. Consensus reflects only the institutions listed, averaging available targets and majority-mapping ratings (Strong Buy/Overweight treated as Buy; Underweight as Sell).
AAPL - Apple Inc.
Large cluster of updates on Oct 31, 2025 following earnings/AI roadmap commentary.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Strong Buy | $320 | 2025-10-31 | Maintained; PT raised from $279 to $320. | https://stockanalysis.com/stocks/aapl/ratings/ |
| Morgan Stanley | Buy (Overweight) | $305 | 2025-10-31 | Maintained; PT raised from $298 to $305. | https://stockanalysis.com/stocks/aapl/ratings/ |
| JP Morgan | Buy (Overweight) | $305 | 2025-10-31 | Maintained; PT raised from $290 to $305. | https://stockanalysis.com/stocks/aapl/ratings/ |
| Bank of America | Strong Buy | $325 | 2025-10-31 | Maintained; PT raised from $320 to $325. | https://stockanalysis.com/stocks/aapl/ratings/ |
| Citigroup | Strong Buy | $315 | 2025-10-31 | Maintained; PT raised from $245 to $315. | https://stockanalysis.com/stocks/aapl/ratings/ |
| Wells Fargo | Buy (Overweight) | $300 | 2025-10-31 | Maintained; PT raised from $290 to $300. | https://stockanalysis.com/stocks/aapl/ratings/ |
Consensus View - Rating: Buy, Target Price: $312 - 6/6 updated Oct 31; broad Buy/Strong Buy skew with PTs $300–$325.
MSFT - Microsoft Corp.
Multiple firms lifted targets into/after FY25 Q4 and fall events; Wells at high end.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $550 | 2025-05-20 | PT raised from $480 to $550. | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-microsoft-stock-price-target-to-550-93CH-4054324 |
| Morgan Stanley | Buy (Overweight) | $650 | 2025-10-30 | Maintained; PT raised from $625 to $650. | https://stockanalysis.com/stocks/msft/ratings/ |
| JP Morgan | Buy (Overweight) | $575 | 2025-10-30 | Maintained; PT raised from $565 to $575. | https://stockanalysis.com/stocks/msft/ratings/ |
| Bank of America | Buy | $585 | 2025-07-18 | PT raised from $515 to $585. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222 |
| Citigroup | Strong Buy | $690 | 2025-10-30 | Maintained; PT raised from $682 to $690. | https://stockanalysis.com/stocks/msft/ratings/ |
| Wells Fargo | Buy | $700 | 2025-10-30 | Maintained; PT raised from $675 to $700. | https://stockanalysis.com/stocks/msft/ratings/ |
Consensus View - Rating: Strong Buy, Target Price: $625 - All six positive; average anchored by $650–$700 topside.
GOOGL - Alphabet Inc. (Class A)
Oct 30, 2025 cluster of updates across coverage after earnings; Wells remains Hold.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Strong Buy | $330 | 2025-10-30 | Maintained; PT raised from $288 to $330. | https://stockanalysis.com/stocks/googl/ratings/ |
| Morgan Stanley | Buy (Overweight) | $330 | 2025-10-30 | Maintained; PT raised from $270 to $330. | https://stockanalysis.com/stocks/googl/ratings/ |
| JP Morgan | Buy (Overweight) | $300 | 2025-10-27 | PT raised from $260 to $300. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660 |
| Bank of America | Buy | $280 | 2025-10-20 | PT raised from $252 to $280. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307 |
| Citigroup | Strong Buy | $343 | 2025-10-30 | Maintained; PT raised from $280 to $343. | https://stockanalysis.com/stocks/googl/ratings/ |
| Wells Fargo | Hold | $268 | 2025-10-30 | Maintained; PT raised from $236 to $268. | https://stockanalysis.com/stocks/googl/ratings/ |
Consensus View - Rating: Buy, Target Price: $309 - 5/6 positive; Wells is outlier Hold at $268.
AMZN - Amazon.com Inc.
Post‑Q3 2025, most banks raised PTs; Morgan Stanley at $315, Citi $320.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $275 | 2025-10-03 | PT raised from $240 to $275. | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016 |
| Morgan Stanley | Buy (Overweight) | $315 | 2025-10-31 | PT raised from $300 to $315. | https://it.investing.com/news/analyst-ratings/morgan-stanley-alza-il-target-di-prezzo-delle-azioni-amazon-a-315-da-300-93CH-3069904 |
| JP Morgan | Buy (Overweight) | $305 | 2025-10-31 | Maintained; PT raised from $265 to $305. | https://stockanalysis.com/stocks/amzn/ratings/ |
| Bank of America | Buy | $272 | 2025-08-06 | Reiterated Buy; $272 PT tied to OpenAI/AWS catalysts. | https://www.investing.com/news/analyst-ratings/bofa-securities-reiterates-buy-rating-on-amazon-stock-amid-openai-partnership-93CH-4173745 |
| Citigroup | Strong Buy | $320 | 2025-10-31 | Maintained; PT raised from $270 to $320. | https://stockanalysis.com/stocks/amzn/ratings/ |
| Wells Fargo | Buy (Overweight) | $292 | 2025-10-31 | Maintained; PT raised from $280 to $292. | https://stockanalysis.com/stocks/amzn/ratings/ |
Consensus View - Rating: Strong Buy, Target Price: $297 - Broad Buy/Overweight; average near $300.
NVDA - NVIDIA Corp.
Wave of target changes after GTC and latest earnings through Nov 2025.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $250 | 2025-11-20 | PT raised from $240 to $250 after earnings. | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369 |
| Morgan Stanley | Buy (Overweight) | $235 | 2025-11-20 | Maintained; PT raised from $220 to $235. | https://stockanalysis.com/stocks/nvda/ratings/ |
| JP Morgan | Buy (Overweight) | $250 | 2025-11-20 | Maintained; PT raised from $215 to $250. | https://stockanalysis.com/stocks/nvda/ratings/ |
| Bank of America | Buy | $275 | 2025-10-29 | Top pick; PT raised from $235 to $275 post‑GTC. | https://finance.yahoo.com/news/analysts-lift-nvidia-price-targets-121925397.html |
| Citigroup | Strong Buy | $270 | 2025-11-20 | Maintained; PT raised from $220 to $270. | https://stockanalysis.com/stocks/nvda/ratings/ |
| Wells Fargo | Buy (Overweight) | $265 | 2025-11-14 | PT raised from $220 to $265. | https://m.uk.investing.com/news/analyst-ratings/wells-fargo-raises-nvidia-stock-price-target-to-265-on-ai-growth-outlook-93CH-4372326 |
Consensus View - Rating: Strong Buy, Target Price: $258 - All six positive; average lifted by BofA/Wells increases.
META - Meta Platforms Inc.
Targets reset lower on 10/30/2025 around higher capex, but still broadly positive.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $815 | 2025-10-30 | PT cut from $870 to $815 post‑earnings. | https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852 |
| Morgan Stanley | Buy (Overweight) | $750 | 2025-07-21 | PT raised from $650 to $750. | https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-750-by-morgan-stanley-4143078 |
| JP Morgan | Buy (Overweight) | $800 | 2025-10-30 | Maintained; PT lowered from $875 to $800. | https://stockanalysis.com/stocks/meta/ratings/ |
| Bank of America | Buy | $810 | 2025-10-30 | PT cut from $900 to $810. | https://www.investing.com/news/analyst-ratings/bofa-securities-lowers-meta-stock-price-target-to-810-from-900-93CH-4318011 |
| Citigroup | Strong Buy | $850 | 2025-10-30 | Maintained; PT lowered from $915 to $850. | https://stockanalysis.com/stocks/meta/ratings/ |
| Wells Fargo | Buy (Overweight) | $802 | 2025-10-30 | Maintained; PT lowered from $837 to $802. | https://stockanalysis.com/stocks/meta/ratings/ |
Consensus View - Rating: Buy, Target Price: $805 - All six positive despite across‑the‑board PT trims on Oct 30.
TSLA - Tesla, Inc.
Only BofA update found in requested-institution set during October 2025 cluster; others not located in our public sources sweep.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | Hold | $471 | 2025-10-29 | Maintained; PT raised from $341 to $471. | https://stockanalysis.com/stocks/tsla/ratings/ |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Rating: Hold, Target Price: $471 - Consensus based on BofA only; other requested banks not found in public summaries reviewed.
AVGO - Broadcom Inc.
AI custom silicon momentum drove several PT raises in Sep–Oct 2025.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $360 | 2025-09-05 | Reiterated Buy; $360 PT post‑quarter. | https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196 |
| Morgan Stanley | Buy (Overweight) | $409 | 2025-10-14 | Maintained; PT raised from $382 to $409. | https://stockanalysis.com/stocks/avgo/ratings/ |
| JP Morgan | Buy (Overweight) | $400 | 2025-09-05 | PT raised from $325 to $400. | https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521 |
| Bank of America | Buy | $400 | 2025-09-05 | PT raised from $300 to $400. | https://www.investing.com/news/analyst-ratings/bofa-securities-raises-broadcom-stock-price-target-to-400-on-ai-growth-93CH-4226065 |
| Citigroup | Strong Buy | $415 | 2025-10-14 | Maintained; PT raised from $350 to $415. | https://stockanalysis.com/stocks/avgo/ratings/ |
| Wells Fargo | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: $397 - 5/6 present; average ~ $397 with tightly-clustered $400± range.
TSM - Taiwan Semiconductor Manufacturing Company Limited (TSMC)
Requested banks’ individual calls were not publicly accessible in our sweep; broader coverage shows Strong Buy from other firms.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - No entries from the six requested institutions found in public summaries; separate third‑party pages show non‑requested analysts at $355–$400.
Highlights
- Apple: all six boosted/maintained on Oct 31; consensus ~$312 Buy.
- Microsoft: Wells $700 top; consensus ~$625 Strong Buy.
- Alphabet: mix includes Wells Hold at $268; consensus ~$309 Buy.
- Amazon: MS $315 and Citi $320; consensus ~$297 Strong Buy.
- NVIDIA: all six positive; consensus ~$258 Strong Buy after Nov earnings.
- Meta: broad PT cuts on 10/30 but Buy-skew; consensus ~$805.
- Broadcom: five banks $360–$415; consensus ~$397 Buy.
- Tesla/TSMC: limited or no public bank updates found; fields left null where not verifiable.
Notes: Ratings nomenclature preserved (e.g., Overweight). Where a bank published multiple 2025 notes, the most recent date and target are used. Consensus figures are simple averages of available targets from the six named institutions only.
IPO Calendar
Timeframe: December 2025 (U.S. listings expected between Dec 1–Dec 31, 2025)
After a busy mid‑year, the U.S. IPO window slowed in November amid a government shutdown–driven SEC backlog; December calendars are light, with smaller operating-company IPOs and SPACs led by boutique underwriters, and a few large candidates monitoring conditions for a potential year‑end launch. Some deals have proceeded via automatic effectiveness under Section 8(a), but timing remains fluid.
New America Acquisition I Corp.
- Expected listing date: 2025-12-04
- Price range: $10.00 per unit (SPAC)
- Shares offered: 30,000,000 units; underwriters’ option up to 4,500,000 additional units
- Exchange: NYSE
- Lead underwriters: Dominari Securities, D. Boral Capital
- Business summary: Blank-check company formed to effect a business combination; intends to target U.S.-centric businesses where management and affiliates have expertise, including technology, healthcare, and logistics (enterprise value target ≥$700 million).
- Notes: Date is tentative; calendars indicate Dec 4, 2025, but the registration was still marked preliminary as of Nov 28, 2025 and effectiveness/pricing could shift. Underwriters shown as co-bookrunners in the S‑1/A.
- Sources: SEC EDGAR: New America Acquisition I Corp. S-1/A (Aug 4, 2025), TickerNewsHub calendar entry (Nov 2025), Reuters filing coverage (Aug 4, 2025)
JM Group Limited (JMG)
- Expected listing date: 2025-12-09
- Price range: $4.00–$5.00 per share
- Shares offered: 3,750,000 ordinary shares; underwriters’ option up to 562,500 shares
- Exchange: NYSE American
- Lead underwriters: Prime Number Capital LLC
- Business summary: Hong Kong‑headquartered merchandise sourcing provider that sources and wholesales a wide array of consumer products (sports/outdoors, toys/games, apparel, electronics, home/tools, seasonal décor, stationery, and personal care) to retailers, distributors, and brand owners; suppliers primarily in mainland China.
- Notes: Underwriting Agreement names Prime Number Capital as representative; listing venue is NYSE American. Public trackers show a tentative Dec 9, 2025 date; timing remains subject to SEC effectiveness and exchange approval.
- Sources: SEC EDGAR: JM Group F-1/A (Oct 8–9, 2025) and Underwriting Agreement (Ex. 1.1), Renaissance Capital profile (company summary), TickerNewsHub calendar entry (Nov 2025)
ANEW Health Limited (AVG)
- Price range: $4.00–$6.00 per share
- Shares offered: 1,800,000 ordinary shares; underwriters’ option up to 270,000 shares
- Exchange: Nasdaq Capital Market
- Lead underwriters: D. Boral Capital LLC
- Business summary: Hong Kong‑based provider of non‑surgical, non‑pharmacological pain‑management and functional‑enhancement services marketed under the ANKH brand; proceeds earmarked for R&D, new service centers (Hong Kong and international), and IT. Proposed ticker ‘AVG’.
- Notes: On file with multiple F‑1/A amendments and a free writing prospectus; marketing timeline not yet disclosed publicly. Some trackers indicate potential mid‑December timing, which remains unconfirmed.
- Sources: SEC EDGAR: ANEW Health F-1/A (Nov 7, 2025), SEC EDGAR: ANEW Health Free Writing Prospectus (Nov 2025)
PayPay (SoftBank’s Japan payments platform)
- Business summary: Mobile QR‑code payments leader in Japan expanding financial services (banking, cards) and cross‑border payments; SoftBank has been gauging investor interest for a potential U.S. IPO with valuation talk around ¥2–3T (~$13–20B+). Timing discussed for as early as December, subject to markets.
- Notes: No U.S. exchange, price range, or share count disclosed as of Nov 28, 2025; the company and SoftBank have not confirmed a definitive U.S. listing timetable.
- Sources: Reuters: PayPay valuation and planned December U.S. IPO (Oct 14, 2025)
BitGo, Inc.
- Business summary: U.S. crypto custody and infrastructure provider; confidentially filed for a U.S. IPO amid sector rebound and increased institutional adoption of digital assets.
- Notes: Confidential filing status; no public timetable, exchange, or terms as of Nov 28, 2025; year‑end launch is possible but uncertain.
- Sources: Reuters: BitGo confidential U.S. IPO filing (Jul 21, 2025)
Medline Industries, LP
- Business summary: Large U.S. medical supplies manufacturer-distributor (PE‑owned) preparing for a marquee U.S. IPO; recent filings/disclosures show growing sales and expanded underwriter lineup; timing indicated for late‑2025 or early‑2026 depending on markets.
- Notes: High-visibility candidate monitoring market conditions; terms, date, and exchange not set publicly as of Nov 28, 2025.
- Sources: Financial Times: Medline readies potential late‑2025 IPO (Oct 2025), Bloomberg: Medline discloses more underwriters and higher sales (Nov 2025)
IPO schedules change quickly, especially around year‑end holidays and when the SEC faces backlogs; issuers often set or shift pricing dates within 7–10 days of launch. Expect additional micro‑cap listings and SPACs to appear intra‑month, and potential postponements if volatility spikes.
Sources
- Stock Ratings: https://finance.yahoo.com/news/analysts-lift-nvidia-price-targets-121925397.html, https://it.investing.com/news/analyst-ratings/morgan-stanley-alza-il-target-di-prezzo-delle-azioni-amazon-a-315-da-300-93CH-3069904, https://m.uk.investing.com/news/analyst-ratings/wells-fargo-raises-nvidia-stock-price-target-to-265-on-ai-growth-outlook-93CH-4372326, https://stockanalysis.com/stocks/aapl/ratings/, https://stockanalysis.com/stocks/amzn/ratings/, https://stockanalysis.com/stocks/avgo/ratings/, https://stockanalysis.com/stocks/googl/ratings/, https://stockanalysis.com/stocks/meta/ratings/, https://stockanalysis.com/stocks/msft/ratings/, https://stockanalysis.com/stocks/nvda/ratings/, https://stockanalysis.com/stocks/tsla/ratings/, https://www.investing.com/news/analyst-ratings/bofa-securities-lowers-meta-stock-price-target-to-810-from-900-93CH-4318011, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-alphabet-stock-price-target-to-280-on-ad-strength-93CH-4296307, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-broadcom-stock-price-target-to-400-on-ai-growth-93CH-4226065, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222, https://www.investing.com/news/analyst-ratings/bofa-securities-reiterates-buy-rating-on-amazon-stock-amid-openai-partnership-93CH-4173745, https://www.investing.com/news/analyst-ratings/broadcom-stock-holds-buy-rating-at-goldman-sachs-on-ai-momentum-93CH-4226196, https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-amazon-stock-price-target-to-275-on-aws-growth-outlook-93CH-4270016, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-microsoft-stock-price-target-to-550-93CH-4054324, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-alphabet-stock-price-target-to-300-on-ai-strength-93CH-4309660, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-750-by-morgan-stanley-4143078
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2025-11-28 at 11:19 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI